Review Article

Recent Advances in Molecular Magnetic Resonance Imaging of Liver Fibrosis

Table 1

Studies that have assessed molecular MRI of liver fibrosis.

Study/yearTargeted moleculesTargeting probesAnimal modelMR effectSignificance

Polasek et al., 2012 [40]Type I collagenEP-3533The rat DEN model & the CCl4 mouse modelShortening the T1 relaxation timeIdentifies fibrotic tissue in animal models of liver fibrosis
Fuchs et al., 2013 [41]Type I collagenEP-3533The CCl4 mouse modelShortening the T1 relaxation timeDiagnoses and stage sliver fibrosis in an animal model
Chow et al., 2013 [42]Fibrin-fibronectin CLT1-peptide-targeted nanoglobular contrast agent
(CLT1(Gd-DOTA))
The CCl4 mouse modelShortening the T1 relaxation timeDetected and stage sliver fibrosis by probing the accumulation of fibronectin
Ehling et al., 2013 [43]Elastin ESMAThe CCl4 mouse modelShortening the T1 relaxation timeElastin-based molecular MRI may be suitable for noninvasive monitoring of ECM remodeling during liver fibrosis
Wang et al., 2011 [44]-Integrinc(RGDyC)-USPIOThe CCl4 mouse modelShortening the T2 relaxation timeTargets HSC imaging with c(RGDyC)-USPIO